Procaps Group S.A. (PROC)
USD 3.0
(-18.7%)
USD 3.0
(-18.7%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 285.93 Million USD | 12.85% |
| 2021 | 253.36 Million USD | -44.26% |
| 2020 | 454.51 Million USD | 8.11% |
| 2019 | 420.43 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q3 | 289.92 Million USD | 0.56% |
| 2023 Q1 | 285.12 Million USD | -0.28% |
| 2023 Q2 | 288.31 Million USD | 1.12% |
| 2022 Q1 | 268.73 Million USD | 6.06% |
| 2022 Q3 | 253.85 Million USD | -1.42% |
| 2022 Q4 | 285.93 Million USD | 12.64% |
| 2022 Q2 | 257.52 Million USD | -4.17% |
| 2022 FY | 285.93 Million USD | 12.85% |
| 2021 Q1 | 452.34 Million USD | -0.48% |
| 2021 FY | 253.36 Million USD | -44.26% |
| 2021 Q4 | 253.36 Million USD | 15.88% |
| 2021 Q3 | 218.64 Million USD | -54.18% |
| 2021 Q2 | 477.18 Million USD | 5.49% |
| 2020 Q1 | 113.62 Million USD | 8.11% |
| 2020 FY | 454.51 Million USD | 8.11% |
| 2020 Q4 | 454.51 Million USD | 300.0% |
| 2020 Q3 | 113.62 Million USD | 0.0% |
| 2020 Q2 | 113.62 Million USD | 0.0% |
| 2019 Q4 | 105.1 Million USD | 0.0% |
| 2019 Q1 | 105.1 Million USD | 0.0% |
| 2019 Q2 | 105.1 Million USD | 0.0% |
| 2019 Q3 | 105.1 Million USD | 0.0% |
| 2019 FY | 420.43 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Theratechnologies Inc. | 58.96 Million USD | -384.899% |
| Harrow Health, Inc. | 190.5 Million USD | -50.096% |
| Dynavax Technologies Corporation | 256.91 Million USD | -11.296% |
| Biofrontera Inc. | 5.39 Million USD | -5196.073% |
| Cronos Group Inc. | 2.53 Million USD | -11157.558% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -46928.783% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 60.039% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | -687.201% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -24276.261% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | -1451.593% |
| Radius Health, Inc. | 365.31 Million USD | 21.729% |
| Universe Pharmaceuticals INC | 5.48 Million USD | -5115.455% |
| DURECT Corporation | 20.74 Million USD | -1278.266% |
| ProPhase Labs, Inc. | 21.38 Million USD | -1237.395% |
| Safety Shot Inc | 1.54 Million USD | -18359.638% |
| Phibro Animal Health Corporation | 525.45 Million USD | 45.584% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -10700.372% |
| Alvotech | 1.07 Billion USD | 73.413% |
| Assertio Holdings, Inc. | 40.91 Million USD | -598.903% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | -588.552% |
| Rockwell Medical, Inc. | 13.43 Million USD | -2027.651% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -43374.658% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | -1588.127% |
| SCYNEXIS, Inc. | 15.08 Million USD | -1796.121% |
| Aytu BioPharma, Inc. | 15.12 Million USD | -1789.98% |
| Viatris Inc. | 18.12 Billion USD | 98.422% |
| OptiNose, Inc. | 131.74 Million USD | -117.03% |
| SIGA Technologies, Inc. | 1.46 Million USD | -19430.959% |
| Tilray Brands, Inc. | 387.31 Million USD | 26.175% |
| PetIQ, Inc. | 468.3 Million USD | 38.942% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -43374.658% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | 33.255% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Alimera Sciences, Inc. | 67.39 Million USD | -324.242% |
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 57.594% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -26188.184% |
| Organogenesis Holdings Inc. | 119.35 Million USD | -139.575% |
| Journey Medical Corporation | 17.73 Million USD | -1512.719% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | -3354.744% |
| Alpha Teknova, Inc. | 30.45 Million USD | -838.785% |
| Clever Leaves Holdings Inc. | 2.08 Million USD | -13600.767% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | -119.343% |
| PainReform Ltd. | 86 Thousand USD | -332382.558% |
| Cosmos Health Inc. | 12.42 Million USD | -2201.482% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | -708.091% |
| TherapeuticsMD, Inc. | 8 Million USD | -3471.955% |
| Embecta Corp. | 1.63 Billion USD | 82.549% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -477996.209% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 586.04 Million USD | 51.209% |
| Incannex Healthcare Limited | 373 Thousand USD | -76558.177% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -27576.977% |
| Shineco, Inc. | 29.65 Million USD | -864.158% |
| Procaps Group, S.A. | 285.93 Million USD | 0.0% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | 9.321% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | -189.343% |
| Lantheus Holdings, Inc. | 616.94 Million USD | 53.653% |
| Alvotech | 1.07 Billion USD | 73.413% |
| Hempacco Co., Inc. | 13.72 Million USD | -1983.39% |
| Eagle Pharmaceuticals, Inc. | 62.46 Million USD | -357.745% |
| Bright Green Corporation | 1.85 Million USD | -15341.064% |
| Esperion Therapeutics, Inc. | 540.94 Million USD | 47.142% |
| Kamada Ltd. | 8.74 Million USD | -3168.207% |
| Indivior PLC | 281.6 Million USD | -1.539% |
| Evoke Pharma, Inc. | 5 Million USD | -5618.7% |
| Flora Growth Corp. | 3.67 Million USD | -7686.901% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -27576.977% |
| Evolus, Inc. | 126.54 Million USD | -125.953% |
| HUTCHMED (China) Limited | 86.13 Million USD | -231.977% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 54.151% |
| Akanda Corp. | 3.99 Million USD | -7050.536% |